These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 32827314)

  • 1. Punicalagin is a neuraminidase inhibitor of influenza viruses.
    Li P; Du R; Chen Z; Wang Y; Zhan P; Liu X; Kang D; Chen Z; Zhao X; Wang L; Rong L; Cui Q
    J Med Virol; 2021 Jun; 93(6):3465-3472. PubMed ID: 32827314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic drug susceptibility assay for influenza virus neuraminidase inhibitors.
    McSharry JJ; McDonough AC; Olson BA; Drusano GL
    Clin Diagn Lab Immunol; 2004 Jan; 11(1):21-8. PubMed ID: 14715540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro evaluation of synergistic inhibitory effects of neuraminidase inhibitors and methylglyoxal against influenza virus infection.
    Charyasriwong S; Watanabe K; Rahmasari R; Matsunaga A; Haruyama T; Kobayashi N
    Arch Med Res; 2015 Jan; 46(1):8-16. PubMed ID: 25523147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro evaluation of the antiviral activity of methylglyoxal against influenza B virus infection.
    Charyasriwong S; Haruyama T; Kobayashi N
    Drug Discov Ther; 2016; 10(4):201-10. PubMed ID: 27558282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influenza A viruses of swine circulating in the United States during 2009-2014 are susceptible to neuraminidase inhibitors but show lineage-dependent resistance to adamantanes.
    Baranovich T; Bahl J; Marathe BM; Culhane M; Stigger-Rosser E; Darnell D; Kaplan BS; Lowe JF; Webby RJ; Govorkova EA
    Antiviral Res; 2015 May; 117():10-9. PubMed ID: 25701593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuraminidase activity provides a practical read-out for a high throughput influenza antiviral screening assay.
    Eichelberger MC; Hassantoufighi A; Wu M; Li M
    Virol J; 2008 Sep; 5():109. PubMed ID: 18822145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inhibitory effect of sodium baicalin on oseltamivir-resistant influenza A virus via reduction of neuraminidase activity.
    Jin J; Chen Y; Wang D; Ma L; Guo M; Zhou C; Dou J
    Arch Pharm Res; 2018 Jun; 41(6):664-676. PubMed ID: 29572682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Competitive fitness of influenza B viruses with neuraminidase inhibitor-resistant substitutions in a coinfection model of the human airway epithelium.
    Burnham AJ; Armstrong J; Lowen AC; Webster RG; Govorkova EA
    J Virol; 2015 Apr; 89(8):4575-87. PubMed ID: 25673705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toll-like receptor 9 ligand D-type oligodeoxynucleotide D35 as a broad inhibitor for influenza A virus replication that is associated with suppression of neuraminidase activity.
    Yamada H; Nagase S; Takahashi K; Sakoda Y; Kida H; Okamoto S
    Antiviral Res; 2016 May; 129():81-92. PubMed ID: 26923882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuraminidase inhibitor susceptibility and neuraminidase enzyme kinetics of human influenza A and B viruses circulating in Thailand in 2010-2015.
    Tewawong N; Marathe BM; Poovorawan Y; Vongpunsawad S; Webby RJ; Govorkova EA
    PLoS One; 2018; 13(1):e0190877. PubMed ID: 29324781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single E105K mutation far from the active site of influenza B virus neuraminidase contributes to reduced susceptibility to multiple neuraminidase-inhibitor drugs.
    Fujisaki S; Takashita E; Yokoyama M; Taniwaki T; Xu H; Kishida N; Sato H; Tashiro M; Imai M; Odagiri T
    Biochem Biophys Res Commun; 2012 Dec; 429(1-2):51-6. PubMed ID: 23131559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro characterization of A-315675, a highly potent inhibitor of A and B strain influenza virus neuraminidases and influenza virus replication.
    Kati WM; Montgomery D; Carrick R; Gubareva L; Maring C; McDaniel K; Steffy K; Molla A; Hayden F; Kempf D; Kohlbrenner W
    Antimicrob Agents Chemother; 2002 Apr; 46(4):1014-21. PubMed ID: 11897583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of Influenza B Virus Variants with Reduced Neuraminidase Inhibitor Susceptibility.
    Farrukee R; Zarebski AE; McCaw JM; Bloom JD; Reading PC; Hurt AC
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30201817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuraminidase from Influenza A and B Viruses is Susceptible to the Compound 4-(4-Phenyl-1H-1,2,3-Triazol-1-yl)-2,2,6,6-Tetramethylpiperidine-1- Oxyl.
    Sacramento CQ; Jordão AK; Abrantes JL; Alves CM; Marttorelli A; Fintelman-Rodrigues N; de Freitas CS; de Melo GR; Cunha AC; Ferreira VF; Souza TML
    Curr Top Med Chem; 2020; 20(2):132-139. PubMed ID: 31880262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substitutions at H134 and in the 430-loop region in influenza B neuraminidases can confer reduced susceptibility to multiple neuraminidase inhibitors.
    Mohr PG; Williams J; Tashiro M; Streltsov VA; McKimm-Breschkin JL
    Antiviral Res; 2020 Oct; 182():104895. PubMed ID: 32750469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influenza B viruses from different genetic backgrounds are variably impaired by neuraminidase inhibitor resistance-associated substitutions.
    Pascua PNQ; Marathe BM; Bisen S; Webby RJ; Govorkova EA
    Antiviral Res; 2020 Jan; 173():104669. PubMed ID: 31790712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Competitive Fitness of Influenza B Viruses Possessing E119A and H274Y Neuraminidase Inhibitor Resistance-Associated Substitutions in Ferrets.
    Pascua PN; Marathe BM; Burnham AJ; Vogel P; Webby RJ; Webster RG; Govorkova EA
    PLoS One; 2016; 11(7):e0159847. PubMed ID: 27466813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fitness costs for Influenza B viruses carrying neuraminidase inhibitor-resistant substitutions: underscoring the importance of E119A and H274Y.
    Burnham AJ; Baranovich T; Marathe BM; Armstrong J; Webster RG; Govorkova EA
    Antimicrob Agents Chemother; 2014 May; 58(5):2718-30. PubMed ID: 24566185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aurintricarboxylic acid is a potent inhibitor of influenza A and B virus neuraminidases.
    Hashem AM; Flaman AS; Farnsworth A; Brown EG; Van Domselaar G; He R; Li X
    PLoS One; 2009 Dec; 4(12):e8350. PubMed ID: 20020057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surveillance for neuraminidase inhibitor resistance in human influenza viruses from Australia.
    Hurt AC; Barr IG; Durrant CJ; Shaw RP; Sjogren HM; Hampson AW
    Commun Dis Intell Q Rep; 2003; 27(4):542-7. PubMed ID: 15508516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.